Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cell-mediated Immune Responses

Cell-mediated Immune Responses

B Cell Activation and Differentiation

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

Vaccinations

Vaccinations

Antigens Involved in Adaptive Immunity

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.

Antigen Presenting Cells

Antigen Presenting Cells

The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Noncanonical IRF3 function mediates STING-dependent pro-inflammatory cytokine production in macrophages.

EMBO reports·2026

Same author

Intranasal DC-targeting vaccine booster elicits durable and cross-clade protective immunity against sarbecoviruses in mice.

The Journal of clinical investigation·2026

Same author

Interleukin 4 selectively expands functional type 1 conventional dendritic cells from bone marrow progenitors.

Cell reports·2025

Same author

MHC II-restricted presentation of soluble antigen by naïve B cells is impaired upon engagement with membrane-associated antigen: A potential mechanism to mitigate autoreactivity.

Journal of immunology (Baltimore, Md. : 1950)·2025

Same author

Mechanistic insight into the induction of liver tissue-resident memory CD8<sup>+</sup> T cells by glycolipid-peptide vaccination.

Cell reports·2025

Same author

Pyroptotic cell corpses are crowned with F-actin-rich filopodia that engage CLEC9A signaling in incoming dendritic cells.

Nature immunology·2024

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

Enhancing immune responses by targeting antigen to DC.

Irina Caminschi¹, Mireille H Lahoud, Ken Shortman

¹The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. caminschi@wehi.edu.au

European Journal of Immunology

|February 7, 2009

Summary

Monoclonal antibodies (mAbs) deliver antigens to dendritic cells (DCs) to stimulate immune responses. This vaccination strategy shows promise in mouse models and is being explored for human clinical trials.

More Related Videos

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

Related Experiment Videos

Last Updated: Jun 25, 2026

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

Area of Science:

Immunology
Vaccinology
Biotechnology

Background:

Monoclonal antibodies (mAbs) targeting cell surface receptors are utilized for antigen delivery.
Dendritic cells (DCs) are key antigen-presenting cells for initiating immune responses.

Purpose of the Study:

To evaluate the efficacy of mAb-mediated antigen delivery to DCs for vaccination.
To identify optimal targets and strategies for DC-based immunisation.
To discuss the translation of this approach to human applications.

Main Methods:

Review of existing literature and data from mouse models.
Discussion of critical parameters for DC targeting and immune response induction.
Exploration of progress in targeting human DCs.

Main Results:

Promising data from mouse models suggest the efficiency of this immunisation strategy.
Identification of key considerations for optimizing DC targeting and immune response generation.

Conclusions:

mAb-based antigen delivery to DCs is a viable and efficient vaccination approach.
Further research is needed to refine targets, DC subtypes, and adjuvant requirements for human application.